Sonelokimab (ALX 0761) is a trivalent bispecific nanobody that incorporates camel-derived, humanized antibodies targeting IL-17F and IL-17A/F, along with antibodies specific to serum albumin VHH. This configuration enhances the plasma half-life of the molecule through its interaction with human serum albumin. Sonelokimab is primarily utilized in research focused on inflammatory conditions such as rheumatoid arthritis and psoriasis, offering a valuable tool for investigating the pathophysiology and potential therapeutic interventions for these diseases.
Sonelokimab (ALX 0761) is a trivalent bispecific nanobody that incorporates camel-derived, humanized antibodies targeting IL-17F and IL-17A/F, along with antibodies specific to serum albumin VHH. This configuration enhances the plasma half-life of the molecule through its interaction with human serum albumin. Sonelokimab is primarily utilized in research focused on inflammatory conditions such as rheumatoid arthritis and psoriasis, offering a valuable tool for investigating the pathophysiology and potential therapeutic interventions for these diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
